Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors, stimulants |
Mechanism KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors), PDGFB stimulants(Platelet-derived growth factor subunit B stimulants), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H12O5 |
InChIKeyWUADCCWRTIWANL-UHFFFAOYSA-N |
CAS Registry491-80-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Legg-Calve-Perthes Disease | Preclinical | China | 02 Jul 2025 | |
| Colitis, Ulcerative | Preclinical | China | 26 Mar 2025 | |
| Neoplasms | Preclinical | China | 01 Apr 2020 |





